ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
6,601
63.80298
1
male
0
27
201
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
0
42,604
29,358.1094
34,901.3438
17.25
black
25.097656
49
0.72998
0.645996
2
0
0
yes
0.5
0.125
no dnr
27
132
5.099609
103
24
36.59375
182.5
1.299805
0.699951
9.398438
138
7.349609
null
null
null
2
1
SIP>=30
1
6,602
45.90799
1
male
1
56
56
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
133,090
87,987.375
97,603.75
43
white
32.398438
60
0.746948
0.666992
1
0
0
no
0.5
0.5
no dnr
56
107
24.597656
129
22
38.59375
245
2.099609
9.298828
2.699707
144
7.40918
null
null
null
null
3
<2 mo. follow-up
3
6,603
63.52597
0
female
0
83
1,386
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
160,341
98,017.375
112,269.125
44
white
38.398438
54
0.484985
0.366943
2
0
0
no
0.4
0.3
no dnr
83
50
22.097656
114
22
38.79688
101.42188
2.099609
1.299805
1.599854
130
7.429688
null
null
null
null
null
null
2.589844
6,604
42.17697
1
male
1
14
14
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$25-$50k
9
55,616
36,861
43,872.9375
49.333313
white
23.796875
34
0.793945
0.669922
2
0
0
no
0.5
0.5
dnr after sadm
14
73
16.796875
104
12
36.19531
236.34375
1.699951
2.5
0.699951
136
7.379883
null
null
null
0
0
<2 mo. follow-up
0
6,605
71.50696
0
male
0
16
1,386
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
9
19,955
13,055.0156
15,637.8672
15
white
40.59375
54
0.343994
0.227997
1
0
0
no
0.8
0.8
no dnr
16
74
1.599854
58
24
34.89844
53.05469
3.399902
4
1.099854
138
7.459961
null
null
null
null
1
no(M2 and SIP pres)
1
6,606
76.78296
1
female
1
58
58
Coma
Coma
0
8
$11-$25k
55
138,632
85,347.3125
98,780.8125
37.5
white
31.199219
49
0.125
0.078995
1
0
0
no
0.75
0.25
dnr after sadm
26
54
29.597656
99
34
38.19531
225
2.599609
1
2
126
7.419922
null
null
null
null
1
<2 mo. follow-up
1
6,607
44.353
1
male
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$11-$25k
100
32,768
21,883.5156
24,289.0312
77
white
55.898438
93
0
0
8
0
0
no
null
null
no dnr
3
30
45.59375
117
34
36.59375
116.92188
3
3.099609
6.5
136
7.229492
null
null
null
null
0
<2 mo. follow-up
0
6,608
64.15295
1
male
0
50
290
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$11-$25k
9
120,896
80,620.25
91,209.75
47.5
black
38.195313
73
0.369995
0.251953
9
1
0
no
0.99
0.97
no dnr
50
142
24
134
10
38.29688
168.875
1.699951
10.099609
4.5
132
7.319336
null
null
null
null
5
SIP>=30
5
6,609
73.15295
0
male
0
9
1,385
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
0
21,349
14,302.0547
15,387.4375
10.5
white
24.199219
40
0.707886
0.619995
12
0
0
no
0.7
0.6
no dnr
9
70
14.298828
63
28
36.89844
395.1875
2.899902
0.699951
6.699219
148
7.509766
null
null
null
null
null
SIP>=30
3.23584
6,610
64.92297
1
female
1
8
8
Lung Cancer
Cancer
2
12
under $11k
0
17,009
10,775.4688
12,258.6797
35
white
34.796875
42
0.230988
0.025997
1
0
0
metastatic
0.3
0.1
dnr after sadm
7
54
6.799805
101
12
36.19531
194.28125
1.899902
0.599976
1.299805
135
7.40918
null
null
null
null
3
<2 mo. follow-up
3
6,611
64.56097
1
male
0
101
110
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
null
0
321,836
210,850.75
231,331.25
50.25
white
23.199219
34
0.74292
0.662964
79
1
0
no
0.75
0.5
no dnr
101
68
23.5
128
12
38.39844
215
2.5
1
1.599854
134
7.399414
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,612
60.19699
1
male
0
65
970
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
178,996
112,564.5
126,922.938
38.5
white
23.898438
44
0.768921
0.694946
13
0
0
no
0.5
0.4
no dnr
65
142
39.296875
136
14
37.79688
174
2.899902
0.799927
0.899902
142
7.459961
null
null
null
null
1
SIP>=30
1
6,613
75.09698
0
male
0
3
1,383
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
1,680
1,162.4287
1,247.84961
7
white
19.699219
25
0.833984
0.728882
1
1
0
no
0.8
0.7
no dnr
3
99
9.099609
93
20
35.69531
338.0625
null
null
1.699951
142
7.449219
null
null
null
0
0
null
0
6,614
80.26794
1
male
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
44
19,288
8,867.4922
10,029.3594
64
white
91.09375
109
0
0
3
0
0
no
0.1
0.001
dnr after sadm
3
0
19.398438
0
0
36.69531
54
2
3.599609
4.399414
130
7.149414
null
null
null
null
7
<2 mo. follow-up
7
6,615
35.98398
0
male
0
8
1,383
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
0
11,756
7,610.8555
8,426.38281
16.5
white
17.5
12
0.929932
0.904907
1
0
0
no
0.95
0.95
no dnr
8
104
13.398438
52
20
38.19531
371.375
3.399902
1.099854
0.899902
139
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
6,616
66.62799
0
female
0
7
1,380
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
9,395
6,109.8984
7,208.35938
18
black
22.199219
29
0.825928
0.767944
1
1
0
no
0.75
0.6
no dnr
7
116
11.798828
109
12
36.59375
360
3.299805
0.5
1.5
140
7.449219
null
null
null
1
1
no(M2 and SIP pres)
1
6,617
56.909
1
male
1
9
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
22,436
11,593.8047
13,237.9531
51
white
38.09375
46
0.536987
0.422974
2
0
0
no
0.05
0.000125
dnr after sadm
8
54
11
115
6
36.09375
106.65625
null
null
1.099854
126
7.5
null
null
null
null
0
<2 mo. follow-up
0
6,618
61.55197
1
male
1
7
7
Coma
Coma
2
null
null
9
40,084
25,945.5625
29,990.4688
32
white
25.699219
61
0.459961
0.386963
14
0
0
yes
0.5
0.2
dnr after sadm
5
103
0.699951
104
36
37.79688
151
2.5
0.899902
1.799805
148
7.519531
null
null
null
null
null
<2 mo. follow-up
2.219238
6,619
36.517
0
male
0
15
1,377
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
27,843
18,594.5625
22,851.4688
27
white
40.695313
54
0.619995
0.515991
1
0
0
no
0.5
0.35
no dnr
15
75
20.398438
129
22
36
200
2.799805
7.199219
5.5
128
7.429688
null
null
null
1
2
no(M2 and SIP pres)
2
6,620
22.76199
0
male
0
6
1,376
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
$25-$50k
9
8,681
5,767.1133
6,647.54688
16
white
23.5
18
0.901978
0.866943
1
0
0
no
0.95
0.95
no dnr
6
100
10.898438
118
33
36.59375
385.6875
3.699707
0.599976
0.699951
135
7.419922
null
null
null
0
0
null
0
6,621
47.71298
1
female
0
8
970
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
8,219
5,388.7266
5,872.59766
13
black
21.398438
35
0.833984
0.728882
1
0
0
no
0.8
0.7
no dnr
8
85
4.799805
116
24
36.5
314.25
1.099854
1.199951
1.799805
136
7.379883
null
null
null
6
6
no(M2 and SIP pres)
6
6,622
48.05499
1
male
1
17
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
null
0
97,107
64,679.1562
71,748.625
37
black
26.5
35
0.703979
0.61499
38
0
0
yes
0.85
0.3
dnr after sadm
14
98
23.199219
148
48
38
184.4375
null
null
1.299805
145
7.379883
null
null
null
null
0
<2 mo. follow-up
0
6,623
77.94098
1
male
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
61
48,901
32,393.4844
39,735.9688
62
white
41.898438
83
0.009998
0.002
7
0
0
yes
0.3
0.3
dnr after sadm
3
61
11.298828
156
26
35.69531
53
2
6.799805
1.399902
140
7.199219
null
null
null
null
2
<2 mo. follow-up
2
6,624
90.22595
1
female
1
10
10
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
26
8,830
5,900.7969
6,138.97656
15.5
white
29.597656
44
0.33197
0.145996
1
0
1
no
0
0
dnr after sadm
1
62
11.398438
118
24
35.59375
192
3
0.399963
0.799927
153
7.379883
null
null
null
null
7
<2 mo. follow-up
7
6,625
66.03699
1
female
0
5
159
Colon Cancer
Cancer
1
12
null
0
3,097
2,165.1621
2,886.67969
17
white
30
38
0.554932
0.231995
1
0
0
metastatic
0.2
0
no dnr
5
67
5.199219
114
20
34.89844
null
3.099609
0.5
1.599854
132
null
null
null
null
0
0
no(M2 and SIP pres)
0
6,626
67.86298
1
female
1
15
15
Coma
Coma
2
8
under $11k
94
29,361
19,186.2812
21,986.4688
38.666657
black
22.699219
32
0.243988
0.177979
1
1
0
no
0.02
0.000008
dnr after sadm
8
70
17.898438
144
12
39.09375
225
2.5
0.599976
0.899902
131
7.459961
null
null
null
null
7
<2 mo. follow-up
7
6,627
70.59796
1
male
1
8
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
55
49,659
33,306.9062
38,328.9688
69
white
50.796875
81
0.009998
0.002
1
1
0
no
0.2
0.1
no dnr
8
44
16.5
116
12
35.09375
105
1.299805
2.899902
4.599609
146
7.219727
null
null
null
null
null
<2 mo. follow-up
3.391602
6,628
52.38898
1
female
0
16
540
MOSF w/Malig
ARF/MOSF
1
12
null
0
39,953
27,074.7031
34,011.0938
19.666656
white
33.195313
54
0.368958
0.250977
19
0
0
yes
0.95
0.9
no dnr
16
61
0.069992
122
24
38.79688
null
3.099609
1.099854
2.099609
132
null
null
null
null
null
2
null
2
6,629
63.64999
1
female
0
16
44
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
17,688
12,061.3438
15,700.9844
27.333328
white
36
42
0.338989
0.222992
3
1
0
yes
0.9
0.8
dnr after sadm
10
105
2.299805
104
24
36.19531
null
3
0.599976
7.399414
123
null
null
null
null
2
null
<2 mo. follow-up
1.839
6,630
84.06598
1
female
0
5
1,067
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
3,843
2,547.4453
2,624.56836
14
white
18.699219
30
0.815918
0.700928
1
1
0
no
null
null
no dnr
5
94
9.298828
74
28
36
385.6875
null
null
1.599854
140
7.609375
null
null
null
null
4
no(M2 and SIP pres)
4
6,631
46.40097
0
female
0
6
1,369
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
5,005
3,216.9316
3,474.75977
11
white
25.699219
19
0.885986
0.809937
1
0
0
no
1
1
no dnr
6
119
27.796875
114
22
36.5
537
null
null
0.899902
128
7.419922
null
null
null
0
0
no(M2 and SIP pres)
0
6,632
59.14899
1
male
0
16
331
ARF/MOSF w/Sepsis
ARF/MOSF
5
9
under $11k
0
21,386
14,476.8516
14,940.1484
10.666664
black
19
28
0.859985
0.810913
4
1
0
no
0.9
0.9
no dnr
16
123
20
100
24
38
null
2.599609
0.299988
1.799805
138
null
null
null
null
2
3
null
3
6,633
47.58899
0
male
0
9
1,369
Cirrhosis
COPD/CHF/Cirrhosis
4
16
>$50k
0
7,535
5,107.9727
5,574.01953
10
white
27.199219
37
0.748901
0.603882
1
0
0
no
1
0.9
no dnr
9
110
10.699219
110
22
35
null
2.899902
3.699707
1.5
135
null
null
null
null
2
3
SIP>=30
3
6,634
76.96399
1
female
1
32
32
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
0
122,608
80,382.25
90,175.1875
38.5
white
21.898438
27
0.727905
0.643921
18
1
0
no
0.7
0.5
dnr after sadm
32
65
21.898438
62
12
36.19531
300
2.599609
0.899902
1.5
131
7.369141
null
null
null
null
0
<2 mo. follow-up
0
6,635
68.56396
1
female
0
8
56
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$11-$25k
9
10,663
7,142.5781
8,017.66797
16
white
24.796875
54
0.756958
0.679932
1
1
0
no
0.5
0.2
no dnr
8
101
11.398438
70
24
36
231.40625
3.599609
0.5
6.199219
132
7.489258
null
null
null
null
7
<2 mo. follow-up
7
6,636
73.01794
0
female
0
7
1,365
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
11,598
7,485.3086
8,272.59375
12.5
white
19.898438
30
0.835938
0.779907
1
0
0
no
0.95
0.95
no dnr
7
106
27.796875
113
24
36.89844
292
3.599609
0.399963
1.099854
138
7.429688
null
null
null
0
0
no(M2 and SIP pres)
0
6,637
41.25897
0
male
0
38
1,366
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
66,635
43,963.4688
48,677.625
34
white
19.898438
16
0.906982
0.873901
1
0
0
no
0.9
0.9
no dnr
38
68
13.298828
103
22
38.09375
182.5
2.899902
0.799927
0.899902
139
7.5
null
null
null
null
0
SIP>=30
0
6,638
79.04999
0
female
0
17
1,366
CHF
COPD/CHF/Cirrhosis
1
10
$11-$25k
0
35,571
18,596.2188
22,001.7969
31.333328
white
28.097656
59
0.674927
0.503906
1
1
0
no
0.5
0.4
no dnr
17
65
12.199219
75
32
36.19531
295
2.099609
0.5
3.5
136
7.419922
null
null
null
null
3
SIP>=30
3
6,639
42.59799
1
male
1
11
11
Lung Cancer
Cancer
3
12
under $11k
0
51,666
33,604.75
35,407.0938
58.5
white
53.796875
63
0.004
0
1
0
0
metastatic
0.1
0.001
dnr after sadm
8
137
14
113
30
35.09375
55
1.099854
5.5
0.399963
134
7.399414
null
null
null
null
6
<2 mo. follow-up
6
6,640
37.073
1
male
0
6
76
CHF
COPD/CHF/Cirrhosis
5
12
under $11k
0
5,109
3,444.1562
3,547.12891
18
white
31.199219
34
0.81897
0.705933
1
0
0
no
0.8
0.6
no dnr
6
86
10.798828
118
22
36.69531
295.1875
2.5
0.5
2
131
7.479492
null
null
null
0
null
null
0.4948
6,641
70.11395
0
female
0
5
1,363
CHF
COPD/CHF/Cirrhosis
2
7
under $11k
0
3,525
2,384.9785
2,525.11914
8
black
15.099609
30
0.893921
0.821899
1
1
0
no
0.8
0.8
no dnr
5
67
4.599609
53
20
36.29688
373.75
4
0.399963
1.5
137
7.439453
null
null
null
1
1
no(M2 and SIP pres)
1
6,642
42.08899
0
male
0
21
1,363
MOSF w/Malig
ARF/MOSF
1
16
$25-$50k
0
66,406
44,127.2188
53,441.1562
25
white
28.5
37
0.521973
0.405945
24
0
0
yes
0.7
0.65
no dnr
21
75
0.079987
77
20
36.79688
null
2.899902
2.599609
1.099854
128
null
null
null
null
0
2
no(M2 and SIP pres)
2
6,643
43.92599
1
male
0
22
52
Colon Cancer
Cancer
1
10
$25-$50k
0
22,780
15,617.7266
18,163.6875
16
white
18.296875
14
0.836914
0.642944
1
0
0
metastatic
0.6
0.3
dnr after sadm
10
117
10.599609
114
20
36.59375
null
3.599609
0.899902
1
136
null
null
null
null
null
0
<2 mo. follow-up
0
6,644
69.51996
1
female
0
17
21
CHF
COPD/CHF/Cirrhosis
2
8
under $11k
9
10,663
7,593.9922
7,954.50781
5.333332
black
30.597656
47
0.567993
0.372986
1
0
0
yes
0.8
0.8
no dnr
17
69
6.399414
120
24
35
276.1875
2.5
1.099854
1.599854
141
7.509766
null
null
null
4
5
<2 mo. follow-up
5
6,645
32.487
0
male
0
11
1,363
ARF/MOSF w/Sepsis
ARF/MOSF
1
7
under $11k
0
12,045
8,052.4062
8,796.75781
18.5
white
30.796875
23
0.819946
0.758911
1
0
0
no
0.8
0.7
no dnr
11
103
12.099609
129
24
35.09375
344.4375
3.199707
2
0.699951
129
7.519531
null
null
null
0
0
no(M2 and SIP pres)
0
6,646
48.00497
0
male
0
5
1,363
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,122
2,744.3144
2,929.08984
6
black
23.898438
25
0.79895
0.675903
1
0
0
no
0.95
0.95
no dnr
5
97
6.899414
114
20
36.69531
295.1875
2.899902
4.5
0.799927
132
7.439453
null
null
null
3
4
no(M2 and SIP pres)
4
6,647
52.09
1
male
0
98
841
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
26
146,637
97,826.875
107,499.812
37
black
30.699219
48
0.560913
0.448975
16
0
0
no
0.6
0.4
no dnr
98
142
38.898438
68
10
36.5
134
3.199707
1.399902
2.599609
155
7.399414
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,648
61.92999
1
male
0
12
56
COPD
COPD/CHF/Cirrhosis
3
6
under $11k
9
20,880
12,499.5859
13,685.4453
21
white
29.699219
42
0.720947
0.564941
1
0
0
no
0.9
0.8
no dnr
12
117
9.599609
133
48
35.5
195.8125
3.299805
1.399902
0.799927
137
7.359375
null
null
null
2
1
<2 mo. follow-up
1
6,649
80.39398
1
male
0
19
40
Coma
Coma
2
8
null
55
17,833
12,272.9688
14,538.4531
17.666656
white
23.5
34
0.293945
0.223999
1
1
0
no
0.5
0.4
dnr after sadm
2
144
18.097656
120
24
38
null
null
1.099854
1.299805
129
7.469727
null
null
null
null
5
<2 mo. follow-up
5
6,650
32.51199
1
male
1
32
32
Cirrhosis
COPD/CHF/Cirrhosis
3
11
under $11k
0
91,929
60,005.625
72,041.3125
42.5
white
43
64
0.442993
0.241974
5
0
0
no
0.6
0.4
dnr after sadm
19
73
36.09375
104
22
36.29688
null
2.299805
35.796875
3.099609
129
null
null
null
null
0
0
<2 mo. follow-up
0
6,651
68.83496
1
male
0
3
347
Lung Cancer
Cancer
2
16
>$50k
0
3,619
2,349.4531
2,504.66992
11
white
11.599609
26
0.793945
0.564941
1
0
0
metastatic
null
null
no dnr
3
77
11.699219
85
20
36.79688
null
4
0.5
1.699951
137
null
null
null
null
null
null
no(M2 and SIP pres)
2.365234
6,652
36.94699
0
male
0
9
1,356
ARF/MOSF w/Sepsis
ARF/MOSF
3
18
under $11k
0
18,359
12,018.5
16,215.0391
29.5
black
37.296875
69
0.69397
0.601929
1
0
0
no
0.9
0.9
no dnr
9
153
11
44
40
35.89844
102.84375
2.299805
4.899414
1.5
135
7.389648
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,653
71.55597
1
female
0
4
481
CHF
COPD/CHF/Cirrhosis
3
6
under $11k
0
3,269
2,109.3984
2,277.51953
11
hispanic
26.097656
36
0.75293
0.609985
1
1
0
no
0.9
0.6
no dnr
4
53
4.899414
62
22
35.39844
285.6875
3.399902
1.399902
1
130
7.429688
null
null
null
2
null
SIP>=30
1.839
6,654
81.45898
1
female
0
6
120
MOSF w/Malig
ARF/MOSF
1
8
under $11k
0
7,343
4,772.5156
5,694.40625
18
white
28
21
0.472961
0.353943
2
0
0
metastatic
0.5
0.2
dnr before sadm
-1
83
22.898438
112
24
35.69531
null
null
null
0.599976
129
null
null
null
null
0
2
no(M2 and SIP pres)
2
6,655
24.44399
0
female
0
8
1,352
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
11,039
7,373.1641
7,918.89844
17.5
black
20.597656
37
0.928955
0.901978
1
0
0
no
0.95
0.95
no dnr
8
68
20.097656
120
28
38.89844
376.1875
2.399902
0.5
1
140
7.419922
null
null
null
2
1
no(M2 and SIP pres)
1
6,656
79.35699
0
female
0
4
1,352
CHF
COPD/CHF/Cirrhosis
2
16
under $11k
0
2,569
1,768.1455
1,901.43945
11
white
25.199219
30
0.731934
0.580933
1
0
0
no
0.8
0.7
no dnr
4
85
6.399414
50
20
36.39844
null
null
0.399963
2.399902
129
null
null
null
null
1
null
no(M2 and SIP pres)
1.1669
6,657
76.93097
1
male
0
5
202
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
44
4,166
2,688.6777
2,902.7793
17
white
17.199219
28
0.719971
0.562988
1
0
1
no
0.7
0.8
dnr after sadm
1
105
12.099609
112
22
36.29688
248
4
0.399963
1.199951
145
7.429688
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,658
56
0
male
0
14
1,350
CHF
COPD/CHF/Cirrhosis
3
9
under $11k
0
26,670
14,787.7266
16,474.625
22.333328
hispanic
23.398438
51
0.851929
0.755981
1
0
0
no
0.25
0.2
no dnr
14
73
11.199219
125
31
38
130
4.199219
1.299805
1.199951
134
7.489258
null
null
null
null
0
no(M2 and SIP pres)
0
6,659
28.47099
1
male
0
25
235
Colon Cancer
Cancer
1
18
$25-$50k
0
24,310
16,874.4062
17,812.5781
12
white
16
5
0.882935
0.733887
1
0
0
metastatic
1
0.75
no dnr
25
96
10.599609
74
20
37.69531
null
3.599609
0.399963
0.699951
135
null
null
null
null
0
0
no(M2 and SIP pres)
0
6,660
37.254
0
male
0
9
1,351
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
15,118
10,010.7344
11,255.7344
18.5
white
27.199219
33
0.849976
0.797974
1
0
0
no
0.99
0.9
no dnr
9
76
33.398438
118
32
38.39844
286.625
2.799805
3.299805
0.699951
130
7.429688
null
null
null
1
1
no(M2 and SIP pres)
1
6,661
55.16498
1
male
1
30
30
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
$11-$25k
0
122,472
80,453
90,847.75
51.5
white
36.398438
60
0.537964
0.422974
7
0
0
no
0.7
0.8
dnr after sadm
28
53
18.597656
117
29
39.19531
145
1.799805
5.299805
1.299805
148
7.389648
null
null
null
null
1
<2 mo. follow-up
1
6,662
55.81699
1
female
0
98
116
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
55
169,530
109,842.25
123,437.062
45
white
30
29
0.454956
0.335999
5
0
0
no
0.6
0.6
no dnr
98
71
15.898438
114
12
36
111.65625
2.199707
0.5
0.599976
142
7.469727
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,663
60.34799
1
male
0
3
205
Lung Cancer
Cancer
1
10
$11-$25k
0
3,128
2,014.3809
2,215.19922
4
white
15.599609
15
0.744995
0.481995
1
0
0
metastatic
null
null
no dnr
3
78
6.799805
98
20
36.09375
null
3.599609
0.199982
1
135
null
null
null
null
null
null
SIP>=30
2.347168
6,664
76.89496
1
male
0
17
26
MOSF w/Malig
ARF/MOSF
2
19
null
9
29,263
19,455.6406
23,673.1875
23.333328
white
23.398438
35
0.594971
0.487
6
0
0
yes
0.5
0.3
dnr before sadm
-5
89
0.179993
71
22
38.09375
null
null
null
1.399902
135
null
null
null
null
null
6
<2 mo. follow-up
6
6,665
57.55798
1
female
1
25
25
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
9
91,058
59,330.0938
66,847
53
white
37.296875
53
0.242981
0.140991
20
0
0
metastatic
0.5
0.5
no dnr
25
61
15.199219
132
28
37.59375
106.65625
1.299805
5.5
0.699951
130
7.389648
null
null
null
null
0
<2 mo. follow-up
0
6,666
67.87396
1
male
0
13
36
ARF/MOSF w/Sepsis
ARF/MOSF
3
7
under $11k
0
19,872
13,052.7031
14,565.9141
20
hispanic
17.5
18
0.843994
0.789917
1
0
0
yes
0.7
0.6
no dnr
13
114
11.599609
67
30
36.59375
380
2.899902
0.5
0.899902
139
7.529297
null
null
null
1
1
<2 mo. follow-up
1
6,667
76.745
1
female
0
74
185
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
155,280
99,237.875
114,867.625
42.25
white
20.699219
31
0.725952
0.641968
5
0
0
yes
0.9
0.5
no dnr
74
58
29.597656
71
10
39.09375
166.65625
2.199707
0.699951
0.799927
141
7.439453
null
null
null
null
0
adl>=4 (>=5 if sur)
0
6,668
71.29895
1
male
0
4
134
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
null
9
13,484
7,040.2148
8,658.79688
27
white
23.796875
35
0.723999
0.638916
4
0
0
no
0.9
0.6
dnr after sadm
3
81
9.199219
138
20
36.59375
283.3125
2.899902
0.299988
8.398438
135
7.429688
null
null
null
1
1
no(M2 and SIP pres)
1
6,669
57.71698
1
female
0
5
14
MOSF w/Malig
ARF/MOSF
1
16
$25-$50k
0
5,169
3,299.7637
4,360.33984
17
white
31.199219
37
0.453979
0.333984
1
0
0
metastatic
0.05
0.000125
dnr after sadm
2
116
2.399902
118
20
36.39844
null
2.699707
0.799927
5.699219
138
null
null
null
null
5
6
<2 mo. follow-up
6
6,670
41.306
0
male
0
8
1,342
Cirrhosis
COPD/CHF/Cirrhosis
3
14
under $11k
0
7,684
5,010.5156
5,581.61719
11
white
27.296875
48
0.784912
0.655884
1
0
0
no
0.8
0.8
no dnr
8
101
10.298828
110
20
37.89844
338.0625
3
9.398438
0.599976
132
7.519531
null
null
null
0
0
no(M2 and SIP pres)
0
6,671
48.51999
0
female
0
7
1,342
Coma
Coma
0
16
$25-$50k
61
9,025
6,035.9375
7,317.09766
30
white
21
13
0.643921
0.583984
1
0
0
no
0.8
0.6
no dnr
7
109
18.097656
62
27
36.29688
596.25
4.299805
0.199982
0.599976
145
7.40918
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,672
30.70799
1
male
0
4
250
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,510
2,412.8984
3,071.56836
11
black
23.398438
29
0.911987
0.851929
1
0
0
no
0.95
0.95
no dnr
4
79
3.599609
110
22
35.79688
446.625
3.599609
1.599854
1.699951
133
7.539062
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,673
68.29596
1
female
1
5
5
Coma
Coma
0
null
null
100
133,305
88,152.25
97,472.125
55
white
25.597656
21
0.052994
0.028
68
0
0
no
null
null
no dnr
5
121
11.599609
138
12
35.29688
212.5
2.599609
0.5
1.199951
150
7.489258
null
null
null
null
null
<2 mo. follow-up
2.839844
6,674
57.98999
1
male
0
18
46
Cirrhosis
COPD/CHF/Cirrhosis
4
8
null
9
40,193
26,652.375
31,694.9688
41
white
24.296875
30
0.665894
0.491943
3
0
0
no
0.9
0.7
no dnr
18
81
22.796875
73
28
36
null
2.299805
3.799805
0.599976
134
null
null
null
null
null
3
<2 mo. follow-up
3
6,675
86.22595
1
female
0
7
8
Coma
Coma
1
12
null
37
17,560
9,003.4609
10,698.1562
25.5
white
21.097656
28
0.348999
0.27594
3
0
0
no
0
0
dnr after sadm
3
128
14.898438
54
24
38
370
3.099609
0.899902
2.399902
137
7.479492
null
null
null
null
7
<2 mo. follow-up
7
6,676
85.35498
1
female
0
161
311
MOSF w/Malig
ARF/MOSF
3
10
under $11k
9
281,985
181,805.75
217,365.125
50.5
white
34.09375
49
0.151978
0.072998
23
0
1
metastatic
0.7
0.6
no dnr
161
53
21.199219
137
36
37.79688
142.21875
null
null
1.199951
132
7.459961
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,677
44.25699
1
female
0
13
20
Lung Cancer
Cancer
1
12
$11-$25k
0
12,040
8,074.7148
10,061.9297
15.5
white
25.398438
24
0.570923
0.248993
1
0
0
metastatic
0.2
0
dnr after sadm
1
85
1.899902
76
12
35.89844
342.8125
3.099609
0.699951
0.599976
131
7.519531
null
null
null
null
0
<2 mo. follow-up
0
6,678
52.14798
1
female
0
59
72
MOSF w/Malig
ARF/MOSF
3
16
null
0
174,127
113,074.812
134,350.5
46.5
white
35.898438
81
0.293945
0.182983
17
1
0
yes
0.8
0.8
no dnr
59
58
0.069992
141
32
39
215
2.799805
0.799927
1.599854
155
7.419922
null
null
null
null
0
null
0
6,679
47.79498
0
male
0
10
1,339
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
14,875
9,237.9219
11,169.1562
19.5
white
26
37
0.8479
0.75
1
0
0
no
0.99
0.8
no dnr
10
113
18.097656
118
28
36.09375
323.75
3.899902
0.5
1.5
125
7.399414
null
null
null
2
2
no(M2 and SIP pres)
2
6,680
74.56494
1
female
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$11-$25k
0
66,352
46,258.3125
51,358.9062
40
white
28.699219
52
0.572998
0.461975
52
0
1
no
0
0
dnr before sadm
-1
57
9.5
130
32
35.39844
290
1.5
0.799927
0.399963
142
7.529297
null
null
null
null
2
<2 mo. follow-up
2
6,681
39.45798
1
male
0
8
1,172
Cirrhosis
COPD/CHF/Cirrhosis
4
11
under $11k
0
7,043
4,771.7617
5,061.45703
5
hispanic
24.597656
32
0.831909
0.724976
1
1
0
no
0.8
0.6
no dnr
8
111
11.398438
96
20
36.59375
null
2.5
0.399963
3.899902
132
null
null
null
null
5
3
no(M2 and SIP pres)
3
6,682
61.31097
1
male
0
3
218
Lung Cancer
Cancer
1
10
$11-$25k
0
4,140
2,697.5898
2,850.92969
8
white
9.199219
17
0.838989
0.646973
1
0
0
metastatic
0.7
0.2
no dnr
3
97
null
101
22
36.29688
null
4.299805
0.5
1.399902
135
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,683
81.224
1
female
0
5
30
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
4,326
2,747.2949
3,274.95898
12
white
13.099609
35
0.830933
0.724976
1
0
0
yes
0.75
0.5
dnr after sadm
1
75
3.599609
70
20
35.79688
204.75
4.399414
0.699951
0.699951
136
7.299805
null
null
null
1
1
<2 mo. follow-up
1
6,684
68.78296
1
male
1
22
22
Cirrhosis
COPD/CHF/Cirrhosis
5
12
under $11k
0
70,108
46,481.1875
53,040.7812
35.666657
white
27.796875
38
0.517944
0.317993
3
1
0
no
0.5
0.4
dnr after sadm
21
71
12.798828
106
26
36.79688
259.25
2.899902
7.399414
1
131
7.449219
null
null
null
null
2
<2 mo. follow-up
2
6,685
85.41498
1
male
1
4
4
Coma
Coma
3
8
under $11k
61
11,734
7,946.3281
8,816.02344
32
white
49.59375
68
0
0
4
0
1
no
0
0
dnr after sadm
1
36
13
46
32
39.5
98.32812
2.799805
0.599976
5.099609
136
7.429688
null
null
null
null
null
<2 mo. follow-up
5.583008
6,686
77.125
1
female
0
6
193
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
3,972
2,723.7598
2,939.7793
9
white
16.398438
27
0.86499
0.775879
1
1
0
no
0.9
0.8
no dnr
6
67
4.899414
100
22
36.19531
null
3.799805
1.699951
1.199951
136
null
null
null
null
1
0
no(M2 and SIP pres)
0
6,687
76.22198
0
male
0
17
1,330
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
26,270
17,649.9688
20,025.2969
16
white
23.097656
26
0.745972
0.665894
4
0
0
no
0.95
0.85
no dnr
17
113
15.298828
60
28
37.59375
144.875
3.599609
1
0.899902
141
7.439453
null
null
null
5
null
SIP>=30
3.855299
6,688
50.702
1
male
0
19
968
COPD
COPD/CHF/Cirrhosis
2
12
null
0
27,858
17,403.3281
19,633.4375
18.666656
white
21.796875
26
0.902954
0.835938
1
0
0
no
0.75
0.6
no dnr
19
110
24.199219
120
32
36.39844
145.6875
3.599609
0.799927
0.899902
144
7.379883
null
null
null
0
0
no(M2 and SIP pres)
0
6,689
74.81696
0
female
0
10
1,328
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
10,632
6,724.168
7,052.36719
20.5
black
30.398438
49
0.620972
0.435974
1
1
0
no
0.9
0.9
no dnr
10
107
15.599609
111
38
36.19531
164.5
3.299805
0.599976
1.899902
138
7.339844
null
null
null
1
0
no(M2 and SIP pres)
0
6,690
77.57397
0
female
0
18
1,328
MOSF w/Malig
ARF/MOSF
1
15
null
26
68,899
45,641.6875
51,858.5312
23.666656
white
27.699219
50
0.34198
0.225983
23
0
0
yes
0.25
0.1
dnr after sadm
3
131
0.089996
76
24
39.39844
null
3.199707
1.699951
1.699951
132
null
null
null
null
null
1
no(M2 and SIP pres)
1
6,691
66.77899
1
female
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
33,506
21,843.0625
23,683.7969
50
white
40.195313
53
0.375
0.255981
4
0
0
no
0.05
0.000125
dnr after sadm
5
126
28
130
30
35.39844
138
2
3.099609
0.5
127
7.429688
null
null
null
null
0
<2 mo. follow-up
0
6,692
65.13898
0
male
0
5
1,326
COPD
COPD/CHF/Cirrhosis
3
4
null
0
4,045
2,666.4102
2,842.74805
11
white
10.099609
20
0.93689
0.891968
1
0
0
no
0.9
0.7
no dnr
5
104
4.799805
77
28
36.79688
328
4.399414
1.099854
0.799927
140
7.389648
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,693
61.435
0
female
0
11
1,325
COPD
COPD/CHF/Cirrhosis
2
null
under $11k
0
21,128
13,303.3438
15,684.6484
32.5
white
26.796875
24
0.79895
0.67688
1
0
0
no
0.8
0.8
no dnr
11
74
35
126
10
36.59375
240
2.799805
0.5
0.599976
144
7.339844
null
null
null
null
0
no(M2 and SIP pres)
0
6,694
45.89999
1
female
0
17
90
Cirrhosis
COPD/CHF/Cirrhosis
2
16
under $11k
9
15,710
10,601.0859
12,727.1484
19.666656
white
29.699219
44
0.680908
0.510986
1
0
0
no
0.7
0.343
no dnr
17
78
10.099609
110
24
37.79688
338.0625
2.799805
30
0.799927
134
7.479492
null
null
null
4
0
adl>=4 (>=5 if sur)
0
6,695
29.073
1
male
0
5
1,237
CHF
COPD/CHF/Cirrhosis
1
12
$25-$50k
0
4,748
3,073.3691
3,483.26953
10
white
14.699219
13
0.956909
0.92688
1
0
0
no
0.8
0.7
no dnr
5
79
14.199219
79
22
37
380.9375
3.899902
2.199707
0.899902
134
7.429688
null
null
null
null
null
no(M2 and SIP pres)
1.852051
6,696
28.81299
1
male
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
54,911
35,893.0938
39,961.2188
52
white
39.796875
69
0.633911
0.531982
4
0
0
no
0.75
0.75
no dnr
10
125
13.5
134
14
39.89844
146
1.899902
10.798828
2.899902
146
7.319336
null
null
null
null
0
<2 mo. follow-up
0
6,697
63.17599
1
female
1
9
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
9
30,752
20,501.6094
23,598.2812
46.5
white
46.59375
79
0.094986
0.037994
6
0
0
yes
0.25
0.15
dnr after sadm
6
69
37.59375
120
40
33.19531
134.6875
2.699707
1.399902
3
130
7.449219
null
null
null
null
1
<2 mo. follow-up
1
6,698
62.004
0
female
0
6
1,324
CHF
COPD/CHF/Cirrhosis
4
9
under $11k
0
6,033
3,833.4531
4,658.6875
14
black
15.798828
29
0.905884
0.840942
1
1
0
no
0.95
0.9
no dnr
6
141
8.5
65
20
36.79688
null
null
0.5
1.599854
140
null
null
null
null
0
0
no(M2 and SIP pres)
0
6,699
60.44098
1
male
1
4
4
Coma
Coma
1
10
under $11k
100
10,197
6,800.8477
7,567.32812
38
white
39.09375
48
0.008999
0.003
1
0
0
no
0
0
dnr after sadm
3
36
11.5
72
22
34
188.5625
2.199707
0.399963
0.799927
135
7.509766
null
null
null
null
null
<2 mo. follow-up
3.190918
6,700
69.50897
0
female
0
4
1,322
CHF
COPD/CHF/Cirrhosis
4
5
null
0
7,024
3,988.1426
5,060.19922
10
white
18
29
0.858887
0.767944
2
1
0
no
null
null
no dnr
4
116
13.298828
81
20
37.89844
null
null
null
1.899902
134
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948